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Abstract: 
Background: Based on the findings of a prior study of CIED (Cardiac Implantable Electrical Device) 
remote monitoring (RM) frequency at the same center, the University of Michigan Congenital Heart 
Center (UMCHC) instituted a quality improvement (QI) change to reduce the frequency of routine 
CIED RM from every 2 months to every 3 months. The objective of this study is to determine the 
impact of this QI initiative to reduce workload without compromising patient care.  
Methods: This is a single center retrospective cohort study of all UMCHC patients with CIEDs 
followed via Medtronic CareLink CIED remote monitoring system from July 2015-June 2017; after the 
QI change in 2014.  The primary outcome was success of transition to new monitoring schedule. 
Secondary outcomes included complications, incidence of actionable events (AES), patient 
compliance, and change in workload.  Outcomes were compared to the prior study. 
Results: There were 325 patients (mean age was 24 ± 14 years) included, of which 293 (90%) 
completely transitioned to the new RM schedule.  During the study period 96 transmissions included 
AES (4% of total), of which 50 (52%) were asymptomatic and discovered on routine monitoring.  No 
patient experienced a complication attributable to decreased RM frequency. The mean number of 
interrogations decreased by 1.6 per patient over the 2-year period compared to prior study.   
Conclusions: This study demonstrated successful implementation of a QI initiative to reduce CIED 
monitoring frequency at a single center with no patient adverse events.  The intervention reduced 
workload and potentially improved patient compliance with routine RM. 
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Introduction:  
Based on remote monitoring guidelines1, in 2014 the University of Michigan Congenital Heart Center 
instituted a change in the frequency of cardiovascular implantable electronic device (CIED) remote 
monitoring from an every 2-month schedule to an every 3-month schedule. This study published in 
the Heart Rhythm Journal by Dechert et al.2 showed that the rate of actionable events, defined as 
requiring a clinical intervention, remained low with the change in schedule for both newly implanted 
and chronic devices. The goals of this change were to improve the quality of care by reducing 
workload without compromising patient care.  Presented here is an assessment of the impact of that 
quality improvement change on workload and patient care.  
Methods:  
This is a retrospective cohort follow up study of all CIED patients followed between July 2015 and 
June 2017 at the University of Michigan Congenital Heart Center and enrolled in the Medtronic 
CareLink remote monitoring system. Patients without any remote monitoring transmissions were 
excluded from the study. This study was approved by the University of Michigan Medical School 
Institutional Review Board.  
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Patient and CIED data were collected from the medical records and from the Medtronic CareLink 
system by individual review of every in-office device interrogation and remotely monitored 
transmission obtained during the study period.  Definitions of the types of transmissions were the 
same as the prior study2.  Routine (i.e asymptomatic) CIED remotely monitored transmissions were 
scheduled to occur every 3 months and were considered compliant if received within 2 weeks before 
or after the scheduled date.  Interrogations were also considered routine if the clinical team 
requested an early follow up interrogation based on prior clinical concerns. Symptomatic 
interrogations included any (remote or in-office) interrogation that was performed specially for 
patient symptoms. Non-routine remotely monitored transmissions were those that were sent in 
prior to the expected interval without reported symptoms.  
The primary quality improvement outcome was successful implementation of the remote 
monitoring schedule change.  Secondary outcomes included complications, incidence of actionable 
events - defined as CIED findings resulting in any clinical intervention, change in workload and 
patient compliance when compared to prior study2. Overall compliance was defined as the number 
of transmissions expected in 1 year, less those not sent by the patient divided by the total number 
expected. A routine transmission was considered “missed” if not received between 2.5 to 3.5 
months after the prior. Data were compared to those from the previous study2. Statistical analysis 
included T-test for continuous variables and Chi-square for categorical variables.   
Results: 
There were 325 patients analyzed, having 2408 total CIED in-office interrogations or remotely 
monitored transmissions.  There were 293 (90%) patients successfully transitioned to the new 
remote monitoring schedule; the remaining 30 (10%) remained on more frequent monitoring for at 
least part of the study period, and 2 never transitioned. Reasons for more frequent monitoring 
included 21 (65%) patients whose devices were nearing elective replacement (ERI), 7 (2%) for closer 
arrhythmia monitoring, and 2 (13%) for other clinical reasons. Two patients did not transition due to 
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significant anxiety surrounding the proposed change. Table 1 shows the demographic information 
and interrogation summary data from both the original study2 and current data.  
Actionable events: Actionable events were identified in 96 (4%) of the total interrogations (remotely 
monitored and in-office). Table 2 shows the type of actionable event including arrhythmia, 
device/lead malfunction and reaching elective replacement indicator (ERI) when compared to the 
prior study2. Of the 96 actionable events, 50 (52%) were noted on asymptomatic/routine remotely 
monitored transmissions, 36 (38%) were associated with symptoms and 10 (10%) were discovered 
on wireless/automatic transmissions. Incidence of and percentage of interrogations showing CIED at 
ERI was higher in the current study than the prior (Table 2).    
Workload: Considering both in-office interrogations and remotely monitored, the mean decrease in 
total transmissions for all patients was 1.6 interrogations per patient over the 2-year study period (p 
value <0.0001 (95% CI 0.837-2.363).   
Compliance:  Compliance improved with the change in frequency of the remote monitoring schedule 
and is shown in table 3.  
Discussion: 
The primary goal of this study was to evaluate the successful implementation of a change in the 
frequency of CIED surveillance monitoring in a single center, implemented as a quality improvement 
initiative. This study showed that 90% of patients successfully transitioned to the new schedule. 
Failure to transition to the new schedule was most commonly due to recommendation by the clinical 
team for more frequent monitoring.  Despite education and reassurance, 2 patients could not 
transition due to significant anxiety related to concerns with less monitoring.  
Importantly, the decreased frequency of CIED monitoring was not associated with any significant 
increase in complications or actionable events.  The intended benefit of this change was decreased 
staff/provider work effort dedicated to processing, reviewing, interpreting and documenting normal 
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and unnecessary remotely monitored transmissions, as well as improved patient compliance with 
surveillance.   Data from the comparative prior study2 showed a low rate (4% of overall 
transmissions) of actionable events identified by routine CIED remote monitoring.  The current study 
continues to show a low rate of (2.5% of overall transmissions), and no increase in, actionable 
events; and most importantly – no recognizable complications from actionable events while on the 
reduced frequency monitoring schedule.    The majority of the actionable events were due to 
arrhythmia requiring treatment or devices reaching elective replacement.  The notable increase in 
percentage of interrogations showing ERI is likely due to 2 factors: 1) a greater incidence by chance 
of CIEDs reaching ERI during the study period; and 2) the decreased monitoring frequency would 
have necessarily decreased the denominator of CIEDs not at ERI, and thereby increased the 
percentage at ERI.  Of the 96 actionable events, only 20 (20%) were related to device or lead 
malfunction and of these, 6 required revision. None were in device dependent patients or were life 
threatening. 
Remote monitoring of CIEDs has been shown to decrease resource utilization of healthcare 
personnel in several large adult trials3,4.  Despite the ease with which patients send remote 
interrogations, the amount of data produced from these reports is extensive.  The time for staff to 
download and prepare these reports, follow up with patients via telephone, and providers to 
interpret these reports is significant and requires dedicated resources. Practices with a large number 
of devices are challenged to develop efficient processes for remote monitoring services because of 
the volume of data received5. Goals to balance high efficiency and high quality care can be 
challenging.  A systematic approach focused on efficiency can decrease resource utilization, yet 
minimize impact on patient care6.  This study highlights such an ongoing effort. 
Based on our center’s experience, it is estimated to require 15 minutes to process each normal 
remotely monitored transmission, which includes staff and physician time for processing, 
interpreting, reporting and patient notification.  The reduction of a mean of 1.6 transmissions per 
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patient in this cohort therefore results in reduction of work load of 130 hours (15 minutes per report 
multiplied by the decrease in 1.6 interrogations per 325 patients) over the 2-year study period. The 
actual magnitude of decrease in remotely monitored transmission frequency was lower than 
expected, however. It was expected that CIED monitoring interrogations for patients should have 
decreased by a total of 4 in the 2-year period, with the decrease in frequency of remotely monitored 
transmissions. The reasons for this shortcoming in reduction was not achieved are likely 
multifactorial.  First, 10% of the patients did not successfully transition to the new schedule either 
because of clinical concerns (ie arrhythmias, lead/device concerns, nearing ERI), or patient or 
provider resistance to the change.  It is speculated that anxiety could have played a role with the 
increase in “non-routine yet asymptomatic tracings” compared to the prior cohort.  Post-hoc 
analysis of the data did not show a difference when comparing the first year versus the second year 
of the study regarding number of non-routine sends.  As familiarity with the new schedule increases, 
these non-routine remotely monitored transmissions are likely to decrease further.  In addition, 
increasing availability of wireless/automatically transmitted data will alleviate physician and patient 
concerns.  Further education and discussion with the patient prior to and during the change in 
schedule may also help alleviate anxiety.  Second, patients are frequently encouraged by telephone 
triage personnel to send transmissions for a variety of complaints, including many highly unlikely 
related to their CIED. Secondary data collected in this quality initiative follow up assessed the 
symptoms associated with the transmissions and will feed back into the monitoring process to 
reduce these unnecessary remotely monitored transmissions. 
Current guidelines1 recommend device interrogation (remotely or in person) every 3–12 months for 
pacemakers and 3-6 months for ICDs.  Based on these, a less frequent than every 3-month schedule 
would be acceptable and may be implemented in the future.  However, the optimal monitoring 
schedule is likely dependent on individual patient parameters.  One key to successful further 
reduction in monitoring frequency will be to fully define those risk factors that lead to asymptomatic 
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or serious actionable events, and assigning more frequent monitoring to those patients only.  Future 
improvements in automated monitoring and transmission of abnormalities to the provider will also 
make routine transmissions obsolete.   
Limitations: 
This is a retrospective study, and patient symptoms and reason for sending remotely monitored 
transmissions were assessed from documentation in the medical record, which may not have been 
complete. This study and the prior were limited to patients enrolled in the Medtronic CareLink 
system because these patients constitute the majority of the patients followed by the University of 
Michigan Congenital Heart Center. In addition, this study compares to a prior study which only used 
patients in the Medtronic CareLink system. Patient compliance has improved but still remains 
suboptimal and may have affected the timing of symptoms and interventions needed. 
 
Conclusions:  
 
This study demonstrates the successful implementation of a quality improvement initiative to 
reduce CIED monitoring at a single center without demonstrable complications or negative effects 
on the patient population.   This intervention potentially improved patient compliance with routine 
remote monitoring.  Despite successful implementation of the intervention, the magnitude of effect 
was less than expected, demonstrating that quality improvements, such as this, may take extended 
time to fully be realized.   
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Table 1: Patient and remote monitoring data (comparison) 
Data Prior Study (every 
2 month) 
Current Study 
(every 3 month) 
p value 
Total number of patients 286 325  
Congenital heart disease 196 (69%) 220 (68%)  
Wireless device 33 (12%) 83 (27%) p=<0.0001 
Age 21±13 years 24±14 years p=0.006 
Total number of interrogations 2614 2408  
In office 792 (28%) 711 (29%)  
    
Remote monitoring transmissions 1822 (70%) 1697 (70%)  
     Routine/Asx      1441 (79%)      1164 (67%) p=<0.0001 
     Nonroutine/Asx      229 (13%)      346 (20%) p=<0.0001 
     Symptomatic      144 (8%)      167 (10%) p=0.038 
     Wireless alert      8 (0.4%)      20 (1%) p=<0.0001 
Interval between transmission/patient 65.4±61.4 days 99±103 days p=<0.0001 
Mean remotely monitored 
transmission/patient 
6±6 5±3.9 p=0.014 
Mean in-office interrogations 3±2 2±1 p=<0.0001 
 
*Data presented in total (%) or Mean (SD) 
†p values >0.2 not listed 
Table 2 Actionable Events (comparison) 
Actionable events Prior Study (every 2 
month) 
Current Study (every 3 
month) 
p value  
Total 129 (5%) 96 (4%)  
     Arrhythmia      66 (47%)      35 (36%) p=0.1 
     Device/lead malfunction      37 (37%)       20 (20%)  p=0.36 
     Elective replacement indicator      26 (23%)      41 (43%) p=<0.0001 
*data presented in total (%) 
Table 3: Compliance Data (comparison)  
Compliance Data Prior Study (every 2 
month) 
Current Study (every 3 
month) 
p value  
Never missed a transmission 21 (7%) 53 (18%) p=0.0002 
Overall compliance (total expected 
–missed/total expected) 
166 (58%) 244 (75%) p=<0.0001 
*data presented in total (%) 
